他汀类药物防治心血管疾病的研究进展

被引：47

作者：

王妍 ^{[1
]}

张梅 ^{[2
]}

柳秋实 ^{[1
]}

李琛 ^{[1
]}

机构：

[1] 济宁医学院护理学院

[2] 山东省工会管理干部学院

来源：

中国老年学杂志 | 2012年 / 32卷 / 09期

关键词：

他汀类药物; 心脑血管疾病; 高血压; 冠心病; 心律失常;

D O I：

暂无

中图分类号：

R54 [心脏、血管（循环系）疾病];

学科分类号：

100201 [内科学];

摘要：

<正>心脑血管疾病的主要病理基础是动脉粥样硬化(AS)。脂质代谢紊乱是引起AS的重要因素。降血脂药物的规范合理使用可以纠正脂质代谢紊乱、预防心脑血管疾病。目前临床上应用最为广泛的调血脂药物是3-羟基-3-甲基戊二酸单酰辅酶A还原酶抑制剂(HMG-CoA)(他汀类)。

引用

页码：1989 / 1992

页数：4

共 8 条

[1]

高脂血症药物治疗研究现状 [J].

周瑞海 ;

高海青 .

中国临床药理学杂志, 1999, (01)

[2]

Effects of statins on early and late results of carotid stenting [J].

Verzini, Fabio ;

De Rango, Paola ;

Parlani, Gianbattista ;

Giordano, Giuseppe ;

Caso, Valeria ;

Cieri, Enrico ;

Isernia, Giacomo ;

Cao, Piergiorgio .

JOURNAL OF VASCULAR SURGERY, 2011, 53 (01) :71-79

[3]

Effect of statins on atrial fibrillation after cardiac surgery: A duration- and dose-response meta-analysis [J].

Chen, Wendy T. ;

Krishnan, Guru M. ;

Sood, Nitesh ;

Kluger, Jeffrey ;

Coleman, Craig I. .

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2010, 140 (02) :364-372

[4]

Association Between Statin Use and the Incidence of Atrial Fibrillation Following Hospitalization for Coronary Artery Disease [J].

Kulik, Alexander ;

Singh, Jagmeet P. ;

Levin, Raisa ;

Avorn, Jerry ;

Choudhry, Niteesh K. .

AMERICAN JOURNAL OF CARDIOLOGY, 2010, 105 (12) :1655-1660

[5]

Statins for Primary Prevention of Cardiovascular Mortality in Women: A Systematic Review and Meta‐Analysis.[J].Radhika N.Bukkapatnam;Nicole B.Gabler;William R.Lewis.Preventive Cardiology.2010, 2

[6]

Clinical Investigations of Statins in Heart Failure: Ventricular Function and Anti-Remodeling.[J].Henry Krum.Heart Failure Clinics.2008, 2

[7]

Effect of statin therapy on risk of ventricular arrhythmia among patients with coronary artery disease and an implantable cardioverter-defibrillator [J].

Chiu, JH ;

Abdelhadi, RH ;

Chung, MK ;

Gurm, HS ;

Marrouche, NF ;

Saliba, WI ;

Natale, A ;

Martin, DO .

AMERICAN JOURNAL OF CARDIOLOGY, 2005, 95 (04) :490-491

[8]

Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels [J].

Ridker, PM ;

Rifai, N ;

Pfeffer, MA ;

Sacks, FM ;

Moye, LA ;

Goldman, S ;

Flaker, GC ;

Braunwald, E .

CIRCULATION, 1998, 98 (09) :839-844

← 1 →